SMC Laboratories, Inc. is pleased to announce a partnership with Repositive, Inc., a UK-based bespoke cancer model search service.

Repositive supports researchers working in oncology to find the right cancer models for their studies. They also organise and curate cancer model data from partner CROs, and present this inventory of models online, via their beta Cancer Models Platform.

Our patented STAM^TM model of NASH-derived hepatocellular carcinoma has been added to Repositive’s platform, the largest directory of preclinical cancer models. We hope that this new partnership will help accelerate the development of life-saving drugs for liver cancer.
Please click here for more information on our liver cancer model.